ESC 365 - A new era in the management of atherosclerotic disease: vascular protection and the COMPASS trial.

HFA Premium Access

A new era in the management of atherosclerotic disease: vascular protection and the COMPASS trial.

Session: Expanding the evidence in heart failure patients

Topic: Clinical

Speaker: Professor M. Cowie (Cambridge, GB)

Sponsored by Bayer AG

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Martin Cowie

AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)

112 presentations

5 followers

6 more presentations in this session

Opening and remarks.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Optimizing stroke prevention in cardiovascular patients and why accurate medication really matters.

Speaker: Professor M. Cowie (Cambridge, GB)

CAD patients with concomitant Heart Failure (HF): are current treatments enough?

Speaker: Professor B. Pieske (Rostock, DE)

Expanding evidence in heart failure patients: the COMMANDER HF trial.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Targeting the heart and associated comorbidities in HF.

Speaker: Doctor R. Mentz (Durham, US)

Access the full session

Expanding the evidence in heart failure patients

Speakers: Professor M. Cowie, Professor F. Zannad, Professor M. Cowie, Professor B. Pieske, Professor F. Zannad...

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources